Late-stage CAFs showed enrichment for Rgs5, Nfkb pathway, Serpins (a1d,a3f, e2, and i1), Timp1, Acta2 expression, and vCAF signatures, while Pdgfrb decreased with tumor progression (Elwakeel et al., 2019). This evidence concerns the gene HCFC1 and neoplasm.